ReviewExpert opinion on pharmacotherapy2023

An update on the use of sphingosine 1-phosphate receptor modulators for the treatment of relapsing multiple sclerosis.

Laura Dumitrescu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.